SCHEMBL6414860

SCHEMBL6414860

O=C1C=CC(=O)c2c([N+](=O)[O-])ccnc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 3/20 0.43
CDC25B P30305 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HIF1A Q16665 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
PDE10A Q9Y233 1/20 0.35
PTPRC P08575 1/20 0.35
MAPT P10636 6/20 0.35
KMT2A Q03164 5/20 0.35
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
MEN1 O00255 4/20 0.35
TDP1 Q9NUW8 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6415761 0.71 SMN1; SMN2 (0.39) S100A4SMN1; SMN2TP53CYP3A4HPGD
SCHEMBL15478974 0.70 S100A4 (0.41) S100A4CDC25B
SCHEMBL6409853 0.70 S100A4 (0.41) S100A4SMN1; SMN2TP53CYP3A4HPGD
SCHEMBL6407772 0.69 S100A4 (0.44) S100A4CDC25BTP53CYP3A4HPGD
SCHEMBL177682 0.69 CDC25B (0.54) S100A4CDC25BTP53CYP3A4HPGD
SCHEMBL7179176 0.69 CDC25B (0.44) S100A4CDC25BKMT2AMEN1TDP1
SCHEMBL30408893 0.67 S100A4 (0.63) S100A4CDC25BSMN1; SMN2TP53CYP3A4
SCHEMBL7625099 0.67 S100A4 (0.63) S100A4CDC25BSMN1; SMN2TP53CYP3A4
SCHEMBL6409655 0.66 TOP1 (0.49) S100A4CDC25BSMN1; SMN2CYP3A4HPGD
SCHEMBL11409834 0.65 S100A4 (0.64) S100A4TP53CYP3A4HIF1ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202993-B1 PHENANTHROLINE-7-ONE DERIVATIVES AND THEIR THERAPEUTIC USES LAFON LABOR (FR) 2005-10-19 EP disclosed
US-6809096-B1 SUCH AS 11-METHOXY-7H-PYRIDO(4,3,2-DE)(1,7)PHENANTHROLINE-7-ONE; ANTITUMOR AGENTS LABORATOIRE L. LAFON (FR) 2004-10-26 US disclosed
US-6583150-B1 Cytotoxic propertie; antitumor; pyrido-(3,2-g)quinoline-5,10-diones; benzo(b)pyrido(4,3,2-de)(1,7)-phenanthroline-8-ones LABORATORIE L. LAFON (FR) 2003-06-24 US disclosed
EP-1202993-A2 PHENANTHROLINE-7-ONE DERIVATIVES AND THEIR THERAPEUTIC USES LABORATOIRE L. LAFON (FR) 2002-05-08 EP disclosed
EP-1161432-A1 PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS LABORATOIRE L. LAFON (FR) 2001-12-12 EP disclosed
WO-2001012632-A2 PHENANTHROLINE-7-ONE DERIVATIVES AND THEIR THERAPEUTIC USES LABORATOIRE L. LAFON (FR) 2001-02-22 WO disclosed
WO-2000055160-A1 PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS LABORATOIRE L. LAFON (FR) 2000-09-21 WO disclosed